Sahajanand Medical Technologies Limited has submitted a regulatory disclosure to both the National Stock Exchange of India Limited (NSE) and BSE Limited regarding a scheduled meeting with analysts/institutional investors. The disclosure is made with reference to the relevant provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The meeting details are as follows:
- Date: November 16, 2026
- Analyst/Investor: AIF Accurate Advisor
- Type of Meeting: Virtual
- Nature of Meeting: One-on-One meet
The disclosure explicitly states that the schedule of the meeting is subject to change due to exigencies on the part of either the investor or the company.
The document is digitally signed by Bhargav Dhirajlal Kotadia, Managing Director & Chief Executive Officer (DIN: 06575042) of Sahajanand Medical Technologies Limited, with the signing timestamp recorded as November 10, 2026 at 21:04:13 +05:30.